Physician profile
Elizabeth A Babin
NPI 1518924133
$11,586.05
in general payments reported to CMS, 2019-2025
24 companies · $2,482 in 2025
The $2,482 reported for 2025 was more than what 86% of Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) providers received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $977 · 2020: $736 · 2021: $1,597 · 2022: $1,807 · 2023: $741 · 2024: $3,247 · 2025: $2,482.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,409 · Food and Beverage: $3,060.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,409.22 |
| Food and Beverage | $3,060.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $6,024.99 | 2020-2024 | Axonics, Bulkamid |
| Medtronic, INC. | $1,868.80 | 2023-2025 | Interstim, Altaviva |
| Valencia Technologies Corporation | $1,145.10 | 2022-2025 | Ecoin Device Kit |
| Medtronic USA, INC. | $801.33 | 2019-2020 | |
| Coloplast Corp | $354.47 | 2022-2025 | Altis, Speedicath |
| Boston Scientific Corporation | $318.27 | 2025 | Axonics |
| Caldera Medical, INC | $200.50 | 2019 | |
| Therapeuticsmd, INC. | $185.78 | 2019 | |
| Mission Pharmacal Company | $125.56 | 2020-2024 | Uribel, Uribel Tabs |
| Coopersurgical, INC. | $110.95 | 2025 | Ally II Ups |
| Femselect INC. | $92.08 | 2025 | Enplace |
| Astellas Pharma US INC | $70.79 | 2020-2021 | |
| Sumitomo Pharma America, INC. | $63.49 | 2023-2025 | Gemtesa |
| Pfizer INC. | $38.98 | 2019-2020 | |
| Urovant Sciences INC | $28.78 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $25.77 | 2021 | |
| Rochester Medical Corporation | $24.57 | 2022 | |
| Laborie Medical Technologies Corp. | $21.81 | 2023 | |
| Olympus America INC. | $21.65 | 2024 | Itind System |
| Exact Sciences Corporation | $18.38 | 2023 | Cologuard Collection Kit |
| Renovia INC | $15.92 | 2019 | |
| Allergan, INC. | $12.84 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $11.74 | 2019 | |
| Ambu INC. | $3.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Babin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.